FDA approves Zepbound® (tirzepatide) as the first and only prescription medicine for moderate-to-severe obstructive sleep apnea in adults with obesity ...Middle East

Averaging up to 20% of weight loss, adults taking Zepbound had at least 25 fewer breathing interruptions each hour as they slept Up to 50% of adults taking Zepbound no longer had symptoms associated with OSA after one year INDIANAPOLIS, Dec. 20, 2024 /PRNewswire/ -- Eli Lilly and Company...

Read More Details
Finally We wish PressBee provided you with enough information of ( FDA approves Zepbound® (tirzepatide) as the first and only prescription medicine for moderate-to-severe obstructive sleep apnea in adults with obesity )

Also on site :

• Sputnik V creator warns of global ‘cat flu’ pandemic
• Former Microsoft engineer fired over protest on Israel AI ties
• Trader Joe's is Giving This Viral Chocolate Bar Its Own Spin and Shoppers 'Can't Wait' To Try It